Signaturefd LLC grew its holdings in shares of CME Group Inc. (NASDAQ:CME – Free Report) by 9.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 5,254 shares of the financial services provider’s stock after buying an additional 457 shares during the quarter. Signaturefd LLC’s holdings in CME Group were worth $1,220,000 at the end of the most recent reporting period.
Other hedge funds have also recently made changes to their positions in the company. Truvestments Capital LLC acquired a new position in shares of CME Group during the third quarter valued at about $26,000. SJS Investment Consulting Inc. grew its holdings in shares of CME Group by 570.6% during the fourth quarter. SJS Investment Consulting Inc. now owns 114 shares of the financial services provider’s stock valued at $26,000 after buying an additional 97 shares during the last quarter. Dunhill Financial LLC boosted its holdings in CME Group by 188.4% during the third quarter. Dunhill Financial LLC now owns 124 shares of the financial services provider’s stock worth $27,000 after purchasing an additional 81 shares during the last quarter. Financial Life Planners purchased a new position in CME Group during the fourth quarter worth about $32,000. Finally, Knuff & Co LLC purchased a new position in CME Group during the fourth quarter worth about $33,000. 87.75% of the stock is currently owned by institutional investors and hedge funds.
Insiders Place Their Bets
In other CME Group news, Director Howard J. Siegel sold 10,000 shares of the firm’s stock in a transaction on Thursday, March 13th. The shares were sold at an average price of $260.00, for a total value of $2,600,000.00. Following the completion of the transaction, the director now directly owns 21,873 shares of the company’s stock, valued at $5,686,980. This trade represents a 31.37 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Julie Winkler sold 11,592 shares of the firm’s stock in a transaction on Thursday, February 13th. The shares were sold at an average price of $249.17, for a total transaction of $2,888,378.64. Following the completion of the transaction, the insider now directly owns 21,885 shares of the company’s stock, valued at approximately $5,453,085.45. The trade was a 34.63 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 27,076 shares of company stock worth $6,871,496 in the last three months. 0.30% of the stock is currently owned by corporate insiders.
CME Group Stock Performance
CME Group (NASDAQ:CME – Get Free Report) last announced its quarterly earnings results on Wednesday, February 12th. The financial services provider reported $2.52 EPS for the quarter, beating analysts’ consensus estimates of $2.46 by $0.06. CME Group had a net margin of 57.52% and a return on equity of 13.62%. On average, sell-side analysts anticipate that CME Group Inc. will post 10.49 earnings per share for the current year.
CME Group declared that its Board of Directors has approved a stock buyback plan on Thursday, December 5th that permits the company to repurchase $3.00 billion in shares. This repurchase authorization permits the financial services provider to repurchase up to 3.4% of its shares through open market purchases. Shares repurchase plans are often an indication that the company’s board of directors believes its shares are undervalued.
CME Group Increases Dividend
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, March 26th. Investors of record on Friday, March 7th will be paid a dividend of $1.25 per share. This is a boost from CME Group’s previous quarterly dividend of $1.15. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.88%. The ex-dividend date of this dividend is Friday, March 7th. CME Group’s dividend payout ratio is presently 51.71%.
Analyst Upgrades and Downgrades
Several research analysts recently weighed in on the stock. Morgan Stanley boosted their price target on shares of CME Group from $256.00 to $263.00 and gave the stock an “equal weight” rating in a report on Wednesday, February 19th. Piper Sandler boosted their price target on shares of CME Group from $250.00 to $258.00 and gave the stock an “overweight” rating in a report on Tuesday, January 7th. Keefe, Bruyette & Woods boosted their price target on shares of CME Group from $256.00 to $257.00 and gave the stock a “market perform” rating in a report on Friday, February 14th. Raymond James upgraded shares of CME Group from a “market perform” rating to an “outperform” rating and set a $287.00 price target on the stock in a report on Monday, March 10th. Finally, Citigroup cut shares of CME Group from a “buy” rating to a “neutral” rating and cut their price target for the stock from $255.00 to $250.00 in a report on Monday, January 6th. Four investment analysts have rated the stock with a sell rating, eight have issued a hold rating and three have assigned a buy rating to the company’s stock. According to MarketBeat.com, CME Group currently has an average rating of “Hold” and an average price target of $238.93.
Read Our Latest Stock Report on CME
CME Group Profile
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Read More
- Five stocks we like better than CME Group
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Arqit Stock Soars as NVIDIA’s GTC Fuels Quantum Excitement
- Value Investing: Is it a Good Strategy in 2022? (Hint: Always)
- 3 Must-Own Stocks to Build Wealth This Decade
- Stock Dividend Cuts Happen Are You Ready?
- Advanced Micro Devices Eyes AI Market Growth—Is AMD a Buy?
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.